Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
62
datasets available to search
ShareScore release 0.9.0
Dataset results
62 results for “CYP”
A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib
ClinicalTrials.gov study NCT03222310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ket
ClinicalTrials.gov study NCT00678756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants
ClinicalTrials.gov study NCT07259330. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
ClinicalTrials.gov study NCT03563287. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD
ClinicalTrials.gov study NCT05643638. IPD Sharing: YES. Countries: 7. Publications: 0.
HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study
ClinicalTrials.gov study NCT05720767. IPD Sharing: NO. Countries: 1. Publications: 0.
Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years)
ClinicalTrials.gov study NCT07303569. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4
ClinicalTrials.gov study NCT01056575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flucloxacillin as an Inducer of CYP-enzymes
ClinicalTrials.gov study NCT04840641. IPD Sharing: NO. Countries: 1. Publications: 0.
Proof-of-concept Study of 'JIA Toolbox' for Children and Young People (CYP) With Juvenile Idiopathic Arthritis (JIA)
ClinicalTrials.gov study NCT05563194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants
ClinicalTrials.gov study NCT02254759. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism
ClinicalTrials.gov study NCT01688544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers
ClinicalTrials.gov study NCT05165628. IPD Sharing: NO. Countries: 1. Publications: 0.
Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability
ClinicalTrials.gov study NCT02568618. IPD Sharing: NO. Countries: 1. Publications: 0.
Antibiotics-induced depletion of rat microbiota induces changes in the expression of host drug-processing genes and pharmacokinetic behaviors of CYPs probe drugs
GEO Series GSE199117. Rattus norvegicus. 12 samples. Type: Expression profiling by high throughput sequencing.
Analysis of seeds from Aethionema arabicum Turkish (TUR) and Cyprus (CYP) accession in response to light
GEO Series GSE125854. Aethionema arabicum. 12 samples. Type: Expression profiling by high throughput sequencing.
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substra
ClinicalTrials.gov study NCT02045966. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast
ClinicalTrials.gov study NCT05016349. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Determine the Effect of Multiple Doses of AZD7325, CYP Study
ClinicalTrials.gov study NCT00790114. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
ClinicalTrials.gov study NCT01260844. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.